A coalition of anti-transgender advocacy organizations has launched a new front in the campaign against gender-affirming care — this time targeting the federal government’s drug regulator.
Several groups that oppose transgender healthcare have filed or supported a citizen petition urging the U.S. Food and Drug Administration (FDA) to investigate and potentially restrict the use of estrogen in transgender medicine.
The effort seeks new warnings, regulatory scrutiny, and possibly new prescribing restrictions on estrogen when it is used as part of gender-affirming hormone therapy for transgender women.
If successful, such a move could impact transgender healthcare nationwide.
But the campaign also hinges on a misunderstanding — or deliberate misrepresentation — of how medicine actually works.
A Petition to Regulate Transgender Hormone Therapy
The FDA petition asks the agency to examine what its supporters call the “off-label use of estrogen in biological males.”
More Stories from QueerDispatch
Among other things, the petition calls for:
- New FDA safety warnings about estrogen prescribed for transgender patients
- Federal review of prescribing practices for gender-affirming hormone therapy
- Public hearings about the risks of estrogen use in transgender medicine
- Potential regulatory action affecting doctors who prescribe it
The organizations backing the petition include several groups known for opposing transgender healthcare policies and lobbying against gender-affirming treatment.
These organizations argue that estrogen therapy for transgender women lacks sufficient long-term safety evidence.
Major medical associations disagree.
The Critical Fact the Petition Downplays: Off-Label Prescribing Is Normal Medicine
At the heart of the petition is the claim that estrogen is being used “off-label.”
Technically, that part is true.
But what the petition does not explain is that off-label prescribing is extremely common and completely legal.
Doctors routinely prescribe medications “off-label” when supported by medical evidence or clinical guidelines.
The FDA approves drugs for specific uses, but the agency does not regulate how doctors practice medicine.
Once a medication is approved for safety and manufacturing standards, physicians can prescribe it for other medically supported uses.
This happens constantly across modern healthcare.
For example:
- Many cancer treatments are prescribed off-label.
- Certain psychiatric medications are widely used for conditions not listed on their original FDA approval.
- Some pediatric treatments are technically off-label because drugs are rarely tested extensively on children before approval.
“Gender-affirming care is associated with better mental health outcomes and reduced depression and suicide risk among transgender youth.”
— American Academy of Pediatrics
Hormone therapy for transgender patients falls into the same category.
Estrogen medications were originally approved for other purposes — such as menopause treatment or hormone disorders — but decades of clinical research and medical practice support their use in transgender care.
Major Medical Organizations Support Hormone Therapy
Gender-affirming hormone therapy is endorsed by numerous mainstream medical institutions.
“Extensive evidence demonstrates that gender-affirming care, including hormone therapy, improves the mental health and overall well-being of transgender and gender-diverse people.”
— American Medical Association
These include:
- The American Medical Association (AMA)
- The Endocrine Society
- The American Academy of Pediatrics
- The World Professional Association for Transgender Health (WPATH)
Clinical guidelines from these organizations recognize hormone therapy as an evidence-based treatment for gender dysphoria.
“Hormone therapy is a medically necessary component of care for many transgender individuals.”
— Endocrine Society Clinical Practice Guidelines
Medical experts say the benefits for transgender patients — including improved mental health and reduced suicide risk — are well documented.
A Familiar Strategy
The petition campaign reflects a broader strategy increasingly used by groups seeking to restrict healthcare access through federal regulatory channels.
Rather than focusing solely on state legislation, advocacy groups have begun targeting federal agencies and regulatory frameworks.
A similar approach was used in attempts to challenge the FDA approval of abortion medication.
By pushing regulators to issue warnings or restrictions, activists can create a foundation for broader legal and political challenges.
Critics say the current petition targeting estrogen appears to follow the same playbook.
Why This Matters for Transgender Healthcare
Even if the FDA ultimately rejects the petition, the effort itself could still have consequences.
Federal warnings or investigations can influence:
- insurance coverage policies
- prescribing behavior among cautious providers
- state legislation regulating transgender healthcare
In practice, regulatory pressure can make treatment harder to access even without a formal ban.
For transgender women who rely on hormone therapy, the stakes are high.
“Gender-affirming treatment is effective and medically necessary for many transgender individuals.”
— American Psychological Association
Hormone therapy is not cosmetic treatment — it is recognized by medical experts as essential healthcare.
A New Front in the Fight Over Trans Healthcare
The political battle over transgender healthcare has largely played out through state laws, court cases, and executive orders.
But the FDA petition suggests a new front is emerging: federal medical regulation.
If anti-trans organizations succeed in reframing hormone therapy as unsafe or experimental, it could open the door to broader national restrictions.
For now, transgender healthcare providers and medical organizations continue to defend the scientific consensus that gender-affirming hormone therapy is both safe and necessary.
And they emphasize a simple fact often missing from political debates:
“Denying transgender people access to medically necessary care can have devastating health consequences.”
— American Medical Association
Doctors prescribe medications off-label every day — because that’s how modern medicine works.
Follow this blog on Mastodon or the Fediverse to receive updates directly in your feed.
Kirstyn Piper Plummer is a Mom, Wife, Photographer, Reporter, IT Administrator and many other things.
[…] fight over transgender rights is no longer limited to healthcare or […]